Search - tctmd.com

Displaying 641 - 660 of 703

Sort: Relevancy | Date

Presentation ICI 2012

Vessix Renal Denervation System: Achieving Safety and Efficacy in Less Than One Minute

Presenter: James R. Margolis

December 02, 2012

Presentation

Potential Lifetime Cost-effectiveness ofCatheter-Based Renal Sympathetic Denervation in Patients with Resistant Hypertension

Presenter: Marc Dorenkamp

November 29, 2012

Presentation TCT 2012

Case: A 62-Year-Old Diabetic Patient with ACS and Moderate Renal Failure

Presenter: Verghese Mathew

October 26, 2012

Presentation TCT 2012

Initiating a Renal Denervation Program

Presenter: George Dangas

October 25, 2012

Presentation TCT 2012

Vincristine Local Delivery for Renal Artery Denervation

Presenter: Christodoulos Stefanadis

October 24, 2012

Presentation TCT 2012

The Clinical Use of Renal Denervation Is Already Expanding Beyond Trial Indications: Insights from the German GREAT Registry

Presenter: Felix Mahfoud

October 24, 2012

Presentation TCT 2012

Sympathetic Renal Denervation: 6 Month Results of the EnligHTN I Study (St. Jude Medical)

Presenter: Vasilios Papademetriou

October 24, 2012

Presentation TCT 2012

Extravascular Renal Denervation (Ablative Solutions)

Presenter: Tim Fischell

October 24, 2012

Presentation TCT 2012

What's Known and Not Known About Renal Denervation for Hypertension: Critical Appraisal of the Clinical Data

Presenter: Deepak Bhatt

October 24, 2012

Presentation TCT 2012

Translational Medicine and Renal Denervation: Preclinical Animal Models and Histoanatomy

Presenter: Renu Virmani

October 24, 2012

Presentation TCT 2012

Renal Sympathetic Denervation as the "Ideal Target" for Refractory Hypertension: Anatomy and Pathophysiology

Presenter: Michael Bohm

October 24, 2012

Presentation TCT 2012

Renal Artery Stenting: What Are the Indications for Intervention in 2012?

Presenter: Christopher White

October 24, 2012

Presentation TCT 2012

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

Catheter-Based Technology Alternatives for Renal Denervation

Presenter: Horst Sievert

October 24, 2012

Presentation TCT 2012

Beyond Renal Denervation

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

Beyond Hypertension: Future Prospects for Renal Denervation Therapy

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

Approach to the Patient with Renal Failure and Multivessel CAD

Presenter: Harry Phillips

October 24, 2012

Presentation TCT 2012

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

Presenter: Michael Joner

October 23, 2012

Presentation TCT 2012

TCT-15. Histo-morphometric Evaluation of 2D Characteristics and 3D Sympathetic Renal Nerve Distribution in Hypertensive vs. Normotensive Patients

Presenter: Giuseppe Sangiorgi

October 23, 2012

Presentation TCT 2012

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

Presenter: Christian Ukena

October 23, 2012

Advertisement

Vessix Renal Denervation System: Achieving Safety and Efficacy in Less Than One Minute

Potential Lifetime Cost-effectiveness ofCatheter-Based Renal Sympathetic Denervation in Patients with Resistant Hypertension

Case: A 62-Year-Old Diabetic Patient with ACS and Moderate Renal Failure

Initiating a Renal Denervation Program

Vincristine Local Delivery for Renal Artery Denervation

The Clinical Use of Renal Denervation Is Already Expanding Beyond Trial Indications: Insights from the German GREAT Registry

Sympathetic Renal Denervation: 6 Month Results of the EnligHTN I Study (St. Jude Medical)

Extravascular Renal Denervation (Ablative Solutions)

What's Known and Not Known About Renal Denervation for Hypertension: Critical Appraisal of the Clinical Data

Translational Medicine and Renal Denervation: Preclinical Animal Models and Histoanatomy

Renal Sympathetic Denervation as the "Ideal Target" for Refractory Hypertension: Anatomy and Pathophysiology

Renal Artery Stenting: What Are the Indications for Intervention in 2012?

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

Catheter-Based Technology Alternatives for Renal Denervation

Beyond Renal Denervation

Beyond Hypertension: Future Prospects for Renal Denervation Therapy

Approach to the Patient with Renal Failure and Multivessel CAD

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

TCT-15. Histo-morphometric Evaluation of 2D Characteristics and 3D Sympathetic Renal Nerve Distribution in Hypertensive vs. Normotensive Patients

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content